A biosimilar to Humira is approved, the FDA Fast Tracks a PTSD drug, and more.
A biosimilar to Humira is approved, the FDA Fast Tracks a PTSD drug, and more.
Phase 3 clinical trials for this non-opioid drug demonstrate significant reductions in pain for osteoarthritis and chronic low-back pain.
